Beat the Press

Dean Baker's commentary on economic reporting


Drug Companies Gone Wild: Medicare Part D

The NYT had a very good piece about how the shift of 6 million Medicaid beneficiaries into the Medicare drug benefit program may increase drug company profits in 2006 by $2 billion. According to the article, under the new program the drug companies get to sell the same drugs at higher prices. It doesn't get much better than this!


Post a Comment

Links to this post:

Create a Link

<< Home